Apollo Endosurgery, Inc. (APEN): Price and Financial Metrics

Apollo Endosurgery, Inc. (APEN)

Today's Latest Price: $3.95 USD

0.02 (0.51%)

Updated Jan 20 6:55pm

Add APEN to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 186 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

APEN Stock Summary

  • Equity multiplier, or assets relative to shareholders' equity, comes in at -80.82 for Apollo Endosurgery Inc; that's greater than it is for only 0.32% of US stocks.
  • The volatility of Apollo Endosurgery Inc's share price is greater than that of 89.38% US stocks with at least 200 days of trading history.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for APEN comes in at -25.26% -- higher than that of only 10.87% of stocks in our set.
  • Stocks that are quantitatively similar to APEN, based on their financial statements, market capitalization, and price volatility, are AEZS, REKR, AVCT, AZUL, and HRB.
  • Visit APEN's SEC page to see the company's official filings. To visit the company's web site, go to www.apolloendo.com.

APEN Stock Price Chart Interactive Chart >

Price chart for APEN

APEN Price/Volume Stats

Current price $3.95 52-week high $5.15
Prev. close $3.93 52-week low $1.24
Day low $3.85 Volume 120,600
Day high $4.15 Avg. volume 67,792
50-day MA $3.36 Dividend yield N/A
200-day MA $2.14 Market Cap 101.85M

Apollo Endosurgery, Inc. (APEN) Company Bio

Apollo Endosurgery, Inc. focuses on the design, development, and commercialization of medical devices for the treatment of obesity. The company offers endo-bariatric products, such as Orbera intragastric balloon system, a non-surgical alternative for the treatment of overweight and obese adults; and OverStitch, an endoscopic suturing system that enables endoscopic procedures by allowing physicians to place full-thickness sutures and secure the approximation of tissue through an Olympus dual-channel flexible endoscope. It also provides surgical products, including Lap-Band system, a system designed to provide minimally invasive long-term treatment of obesity; and accessories used in laparoscopic bariatric surgeries. The company is based in Austin, Texas.

APEN Latest News Stream

Event/Time News Detail
Loading, please wait...

APEN Latest Social Stream

Loading social stream, please wait...

View Full APEN Social Stream

Latest APEN News From Around the Web

Below are the latest news stories about Apollo Endosurgery Inc that investors may wish to consider to help them evaluate APEN as an investment opportunity.

Weight Loss Management Market to Witness Huge Growth by 2027| Key Players are Cybex International, Ediets.Com, Equinox, Amer Sports, Apollo Endosurgery, Jenny Craig, Johnson Health Technology, Atkins Nutritionals, Brunswick Corporation, Medtronic, Herbali

ReportsnReports.com the exclusive leading provider of market research reports published research report on “Global Weight Loss Management Market Research Report 2021”. The Global Weight Loss Management Market Report 2021 is a professional and in-depth study on the current state of the

OpenPR | January 12, 2021

Apollo Endosurgery to Present at HC Wainwright Bioconnect Conference - Stocks News Feed

AUSTIN, TX / ACCESSWIRE / January 5, 2021 / Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today announced that it will participate in the H.C. Wainwright Bioconnect 2021 Conference taking place virtually January 11-14, 2021. Management will provide a pre-recorded presentation which will be… Read More »Apollo Endosurgery to Present at HC Wainwright Bioconnect Conference

Stocks News Feed | January 5, 2021

Assessing Apollo Endosurgery

Today we take our first look at a small medical concern that has been put through the ringer in 2020 thanks to the impacts of the pandemic. Company Overview: Apollo Endosurgery, Inc. (APEN) is an Austin, Texas based medical technology concern focused on the development of devices to improve gastrointestinal...

Busted IPO Forum on Seeking Alpha | December 27, 2020

Apollo Endosurgery Receives FDA Clearance for the X-Tack(TM) Endoscopic HeliX Tacking System

AUSTIN, TX / ACCESSWIRE / December 15, 2020 / Apollo Endosurgery, Inc.

Yahoo | December 15, 2020

Where Do Hedge Funds Stand On Apollo Endosurgery (APEN)?

Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that’s why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an […]

Yahoo | December 2, 2020

Read More 'APEN' Stories Here

APEN Price Returns

1-mo 13.83%
3-mo 128.32%
6-mo 120.67%
1-year 31.67%
3-year -35.03%
5-year -71.50%
YTD 16.18%
2020 19.30%
2019 -17.39%
2018 -38.39%
2017 -53.95%
2016 -31.34%

Continue Researching APEN

Want to see what other sources are saying about Apollo Endosurgery Inc's financials and stock price? Try the links below:

Apollo Endosurgery Inc (APEN) Stock Price | Nasdaq
Apollo Endosurgery Inc (APEN) Stock Quote, History and News - Yahoo Finance
Apollo Endosurgery Inc (APEN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8455 seconds.